New "me-too" beta blocker dissed by experts

The Wall Street Journal health blog pokes fun at Bystolic, the newly approved beta blocker from Forest Laboratories and Mylan Laboratories, as the ultimate "me-too" drug. It's number 19 in the list of beta blockers now available in the U.S. The developers counter by saying that the drug has "placebo-like" side effects, making compliance easier. One Mayo Clinic expert cautions the numbers are coming from small studies, and with Glaxo's Coreg going generic, he's going with the lower cost drug.

- read the blog item

Related Articles:
Mylan CEO intent on new global biz. Report
Mylan takes majority stake in Matrix. Report